ArticleBiosensors2026
Inductor-Based Biosensors for Real-Time Monitoring in the Liquid Phase.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Current liquid-phase resonant biosensors, such as Quartz Crystal Microbalance, Surface Acoustic Wave, or Surface Plasmon Resonance, typically rely on specialized piezoelectric substrates or complex optical setups. These requirements often necessitate cleanroom fabrication, thereby limiting cost-effective scalability. This study presents a high-integration sensing platform based on standard Printed Circuit Board (PCB) technology, incorporating an embedded inductor within a fluidic system for real-time monitoring. This design leverages industrial manufacturing standards to achieve a compact, low-cost, and scalable architecture. Detection is governed by shifts in the resonance frequency of an LC tank circuit; specifically, increases in bulk ionic strength induce a frequency decrease, whereas biomolecular adsorption at the sensor surface leads to a frequency increase. This phenomenon can be explained by the modulation of the inter-turn capacitance, which is modeled as a combination of capacitive elements accounting for contributions from the bulk electrolyte and the surface-bound dielectric layer. Such divergent responses provide an intrinsic self-discriminating capability, allowing for the analytical differentiation between surface interactions and bulk effects. To the best of our knowledge, this is the first demonstration of an inductor-based resonant sensor fully embedded in a PCB fluidic architecture for continuous liquid-phase analyte monitoring. Validated through a protein-antibody model (Bovine Serum Albumin-anti-Bovine Serum Albumin), the sensor demonstrated a limit of detection of 1.7 ppm (0.026 mM) and a linear dynamic range of 31-211 ppm (0.47-3.2 mM). These performance metrics, combined with a reproducibility of 4 ± 3%, indicate that the platform meets the requirements for robust analytical applications. Its inherent simplicity and potential for miniaturization position this technology as a viable candidate for point-of-care diagnostics in diverse environments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.